Candriam S.C.A. Artivion, Inc. Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$22.32 - $32.07 $650,985 - $935,353	-29,166 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$16.76 - $23.74 $12,787 - $18,113	763 Added 2.69%	29,166 $689,000
Q3 2020 Oct 19, 2020	SELL	$16.35 - $21.4 $212,550 - $278,200	-13,000 Reduced 31.4%	28,403 $525,000
Q2 2020 Jul 23, 2020	SELL	$16.34 - $25.24 $58,774 - $90,788	-3,597 Reduced 7.99%	41,403 $794,000
Q3 2017 Nov 03, 2017	BUY	$18.85 - $23.05 $848,250 - $1.04 Million	45,000	45,000 $1.02 Million

175

35.9M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.08B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.